2nd DIA China Annual Meeting
| Date: | May 16- 19, 2010 |
| Venue: | Crowne Plaza Sun Palace Beijing |
| Organizer: | Drug Information Association |
Introduction
China’s drug innovation and development are moving ahead rapidly. A local, as well as global, perspective will help all players involved to exchange critical information for research and strategic positioning in an increasingly complex regulatory landscape.
This second DIA China Annual Meeting will serve as an international, neutral forum for attendees to collectively discuss how China can play a leadership role in drug development. Speakers from major regulatory agencies, industry, and academia will present and lead the panels and sessions.
This multidisciplinary meeting will benefit all professionals from regulatory agencies and institutions, the biopharmaceutical industry, investigational sites, contract research organizations, and academia. Together we can better understand how to reach the next stage for our profession as well as deliverbenefi ts for human health and well-being globally.
KEY SESSIONS AND TOPICS
General Session Topics
• Regulatory Affairs (4 sessions)
• Clinical Research (4 sessions)
• Pharmacovigilance (2 sessions)
• Clinical Data Management and Statistics (2 sessions)
• Non-clinical Safety Assessment (1 session)
• CMC/GMP (1 session)
• R&D and Biotechnology (2 sessions)
Target Audience:
This program will benefit individuals involved in:
• Regulatory affairs
• Clinical research
• Drug R&D strategies
• Quality assurance and quality control
• Drug safety and pharmacovigilance
• Strategic sourcing/planning
• Bioinformatics
• Biostatistics
Contact Info
CONTACT INFORMATION
Conference: For general inquiries and registration, contact Ms. Stephanie Liu at dia@diachina.org
Exhibits: Ms. Tina Peng at: dia@diachina.org
Return to Conference Home